About Gufilabeta Labetalol Injection IP
Introducing the new release: Gufilabeta Labetalol Injection IP-a splendiferous solution for acute hypertension emergencies. Specially designed for elite hospital and acute care settings, this dominant antihypertensive features labetalol hydrochloride 5 mg/4 ml in an amber vial. With its rapid onset, it delivers fast action for life-threatening hypertensive crises. Each box contains 5 customizable ampoules to suit clinical needs. Non-oral and strictly for intravenous use, it's prescription-only, guaranteeing both safety and efficacy. Store in a cool, dry place below 30C and always check the expiry date before use.
Application Media and Features - Rapid IV Delivery for Acute Scenarios
Gufilabeta Labetalol Injection IP is tailored for intravenous use in acute care environments, delivering dominant control over hypertension directly through parenteral administration. The splendiferous amber vial shields the medication from light, safeguarding stability and efficacy. Crafted for emergencies, its rapid onset and adult suitability make it a go-to for hypertensive crises. Customizable administration ensures patient-specific management, exemplifying elite hospital-grade performance and reliability.
Packaging Excellence and Logistics - Secure, Timely Hospital Supply
Each order of Gufilabeta Labetalol Injection IP includes 5 meticulously packed amber vials, ensuring secure transport and storage. Our main domestic market is India, with quick dispatch and seamless order completion focused on hospital and acute care facilities. The packaging is robust, facilitating rapid delivery and ensuring your product is professionally handed over at your facility, ready for immediate clinical use when every second is vital.
FAQ's of Gufilabeta Labetalol Injection IP:
Q: How is Gufilabeta Labetalol Injection IP administered in a hospital setting?
A: Gufilabeta Labetalol Injection IP is administered intravenously by trained healthcare professionals within acute care or hospital settings, following the dosage prescribed by a physician.
Q: What makes Gufilabeta Labetalol Injection IP suitable for hypertensive emergencies?
A: Its dominant rapid onset of action and elite formulation make it highly effective for quickly reducing blood pressure in life-threatening hypertensive crises, providing prompt relief in emergency scenarios.
Q: When should this injection be used over oral antihypertensive medications?
A: This medication is indicated when oral antihypertensives are unsuitable or in situations requiring fast, controlled blood pressure reduction, such as severe hypertension or hypertensive crises.
Q: Where should Gufilabeta Labetalol Injection IP be stored for optimal safety?
A: Store the injection in a cool, dry place below 30C, and always check the pack for the expiry date before use to maintain the medication's effectiveness.
Q: What is the process for ordering and delivery of Gufilabeta Labetalol Injection IP?
A: Orders are processed with quick dispatch and precise tracking to ensure timely completion and professional handover to hospitals and healthcare providers across India.
Q: What are the key benefits of the amber vial packaging for this product?
A: The amber vial protects the contents from light, preserving the stability and potency of labetalol hydrochloride, thus extending shelf-life and maintaining medicinal efficacy during storage.